Investment Rating - The investment rating for the company is "Outperform" (Maintain) [1][3] Core Views - The company reported a revenue of 1.032 billion yuan for 2025, a year-on-year decrease of 16.72%, and a net profit attributable to the parent company of 195 million yuan, down 7.68% year-on-year. The earnings forecast for 2025 has been revised down, while the forecasts for 2026 and 2027 remain unchanged, with expected net profits of 269 million yuan and 350 million yuan respectively. The current stock price corresponds to P/E ratios of 31.2, 22.6, and 17.3 for 2025, 2026, and 2027 respectively. The company is optimistic about the recovery in the downstream organic silicon and pesticide industries, as well as the delivery of electronic-grade hydroxylamine salt water solution products, hence maintaining the "Outperform" rating [3][4]. Company Overview - The company is a leading enterprise in the domestic silane crosslinking agent and hydroxylamine salt segment, focusing on the research, production, and sales of ketoxime series fine chemicals. Its main products include silane crosslinking agents, hydroxylamine salts, methoxyamine hydrochloride, and acetaldehyde oxime, which are widely used in construction materials, energy, electronics, new energy vehicles, and metal beneficiation [4][5]. Product Development - By the end of 2025, the company successfully delivered electronic-grade hydroxylamine water solution orders to end-chip customers. This high-end product is used as a cleaning agent in aluminum processing for chip manufacturing. The company has developed a safe and green preparation process for hydroxylamine, breaking the technical monopoly in the industry. The quality of its electronic-grade hydroxylamine water solution is comparable to that of BASF's products and has been validated by several chip manufacturing and cleaning agent compounding companies [5]. Financial Summary and Valuation Indicators - The financial summary indicates that the company's revenue is projected to recover to 1.339 billion yuan in 2026, with a year-on-year growth of 29.7%. The net profit is expected to increase to 269 million yuan in 2026, reflecting a growth rate of 37.9%. The gross margin is anticipated to improve from 29.6% in 2025 to 30.8% in 2026, while the net margin is expected to rise from 18.9% to 20.1% in the same period. The EPS is projected to be 1.98 yuan in 2026, with a P/E ratio of 22.6 [7][10].

Investment Rating - The investment rating for the company is "Outperform" (Maintain) [1][3] Core Insights - The company reported a revenue of 1.032 billion yuan for 2025, a year-on-year decrease of 16.72%, and a net profit attributable to shareholders of 195 million yuan, down 7.68% year-on-year [3] - The company has adjusted its 2025 profit forecast but maintains its profit projections for 2026 and 2027, expecting net profits of 195 million (originally 201 million), 269 million, and 350 million yuan respectively, with corresponding EPS of 1.44, 1.98, and 2.58 yuan [3] - The company is optimistic about the recovery in the downstream organic silicon and pesticide industries, as well as the delivery of electronic-grade hydroxylamine salt water solution products [3] Financial Summary - The company achieved a revenue of 1.115 billion yuan in 2023, with a projected increase to 1.339 billion yuan in 2026 and 1.616 billion yuan in 2027, reflecting a year-on-year growth of 29.7% and 20.7% respectively [7] - The gross profit margin is expected to improve from 29.6% in 2025 to 30.8% in 2026 and 32.5% in 2027 [10] - The net profit margin is projected to increase from 18.9% in 2025 to 20.1% in 2026 and 21.7% in 2027 [10] Industry Position - The company is a leader in the niche market of silane crosslinking agents and hydroxylamine salts, focusing on the research, production, and sales of ketoxime series fine chemicals [4] - It has established a green circular industrial chain with a strong competitive advantage, supported by a robust intellectual property system with multiple authorized patents [4] - The successful delivery of electronic-grade hydroxylamine water solution to chip manufacturers marks a significant milestone, as this product has high purity requirements and is critical for chip manufacturing processes [5]

Investment Rating - The report assigns a "Buy" rating for the company, marking the first coverage of the stock [1]. Core Insights - The company, Zhejiang Jinhua New Materials Co., Ltd., is a leading supplier of ketoxime products and has established a strong position in the fine chemical industry, particularly in silane crosslinking agents and hydroxylamine salts [9][14]. - The hydroxylamine salt market is expanding, driven by increased demand in downstream industries such as agriculture, pharmaceuticals, and electronics, which opens up long-term growth opportunities for the company [9][40]. - The company has a robust technical innovation capability and a rich customer base, including partnerships with major international and domestic chemical companies [9][57]. Summary by Sections 1. Company Overview - Zhejiang Jinhua New Materials specializes in the R&D, production, and sales of ketoxime series fine chemicals, including silane crosslinking agents and hydroxylamine salts [9][14]. - The company has received numerous accolades, including being recognized as a national "little giant" enterprise and a high-tech enterprise [14]. 2. Market Dynamics - The fine chemical industry is a strategic focus in China's chemical sector, with hydroxylamine salts being a key raw material for various applications, including low-toxicity pesticides and high-efficiency metal extractants [40][39]. - The global hydroxylamine salt market is projected to grow from 2.714 billion yuan in 2023 to 3.179 billion yuan by 2028, with a CAGR of 3.21% [40][41]. 3. Technical Innovation and Customer Base - The company has established a green circular industrial chain for ketoxime products, showcasing its commitment to sustainable practices and innovation [16][57]. - Jinhua New Materials has built a strong customer network, including partnerships with Bayer and domestic leaders like Wanhua Chemical, ensuring a stable demand for its products [60][57]. 4. Financial Projections - The company is expected to achieve revenues of 1.064 billion yuan in 2025, with a projected net profit of 198.77 million yuan, reflecting a growth trajectory despite a slight decline in 2025 [1][21]. - The earnings per share (EPS) are forecasted to be 1.47 yuan in 2025, with a P/E ratio of 34.00, indicating a favorable valuation compared to peers [1][21].

Investment Rating - The report assigns a "Buy" rating for the company, marking the first coverage of the stock [1]. Core Insights - The company, Zhejiang Jinhua New Material Co., Ltd., is a leading supplier of ketoxime products, focusing on the research, production, and sales of fine chemical products, particularly silane crosslinkers and hydroxylamine salts [9][14]. - The hydroxylamine salt market is expanding, driven by increased demand in downstream industries such as agriculture, pharmaceuticals, and environmental applications [40][44]. - The company has established a green circular industrial chain, showcasing its commitment to sustainable practices and innovation in production processes [16][57]. Summary by Sections 1. Company Overview - Zhejiang Jinhua New Material Co., Ltd. specializes in ketoxime series fine chemicals and has received numerous accolades, including being recognized as a national "little giant" enterprise [14]. - The company has developed a unique green circular industrial chain for ketoxime products, enhancing its competitive edge [16]. 2. Market Dynamics - The fine chemical industry is a strategic focus in China's chemical sector, with hydroxylamine salts experiencing stable market growth due to their applications in various high-demand sectors [39][40]. - The global hydroxylamine salt market is projected to grow from 2.714 billion yuan in 2023 to 3.179 billion yuan by 2028, with a CAGR of 3.21% [40][41]. 3. Financial Performance - The company forecasts revenues of 1.064 billion yuan in 2025, with a projected net profit of 198.77 million yuan, reflecting a slight decline from the previous year [1]. - The earnings per share (EPS) is expected to be 1.47 yuan in 2025, with a P/E ratio of 34.00 [1]. 4. Competitive Position - The company has established itself as a market leader in silane crosslinkers and hydroxylamine salts, with significant market shares of 38.16% and 42.37% respectively by 2024 [57][58]. - It has built a robust customer base, including major international and domestic companies, ensuring stable demand for its products [60]. 5. Technological Innovation - The company has developed high-purity electronic-grade hydroxylamine water solution, breaking the monopoly of foreign firms and filling a gap in the domestic market [61]. - It has a strong focus on R&D, with several patents granted for its innovative production processes, ensuring product quality and environmental sustainability [63].

Investment Rating - The report assigns an "Accumulate" rating for the company, marking its first coverage [3]. Core Insights - The company is a leading player in the domestic silane crosslinking agent and hydroxylamine salt sectors, with a unique "oxime-silane-hydroxylamine salt" green circular industry chain that showcases industry-leading technology [3][12]. - The company is expected to benefit from the growing demand in the new energy vehicle and electronics sectors, with projected net profits of 201 million, 269 million, and 350 million yuan for 2025, 2026, and 2027 respectively, corresponding to EPS of 1.48, 1.98, and 2.58 yuan per share [3][4]. - The company has successfully developed electronic-grade hydroxylamine water solution, breaking the monopoly of foreign manufacturers and supporting the localization of semiconductor cleaning agents [5][12]. Financial Summary - The company’s revenue is projected to reach 1.239 billion yuan in 2024, with a net profit of 211 million yuan, reflecting a year-on-year growth of 11.2% and 22.3% respectively [4][39]. - The gross profit margin is expected to improve from 27.7% in 2023 to 32.5% in 2027, while the net profit margin is projected to increase from 15.5% to 21.7% over the same period [4]. - The company’s earnings per share (EPS) are forecasted to be 1.48 yuan in 2025, 1.98 yuan in 2026, and 2.58 yuan in 2027, with corresponding price-to-earnings (P/E) ratios of 38.6, 28.9, and 22.2 [3][4]. Industry Outlook - The fine chemical industry is experiencing rapid growth, with China's fine chemical industry output expected to exceed 11 trillion yuan by 2027, reflecting a compound annual growth rate of over 19.17% from 2024 to 2027 [55]. - The demand for silane crosslinking agents is anticipated to expand significantly, driven by applications in construction materials, energy, electronics, and new energy vehicles [61][66]. - The production of functional silanes in China is projected to grow from 46.90 million tons in 2024 to 59.88 million tons by 2028, indicating a compound annual growth rate of 6.30% [65][68].

Core Insights - The core viewpoint of the article is that the hydroxylamine salt market in China is stabilizing, with a notable recovery in sales driven by the agricultural sector and increasing export demand [1][2]. Group 1: Market Trends - The production of chemical pesticide raw materials in China is projected to reach 3.675 million tons in 2024, with a growth rate of 37.6% [2]. - The sales volume of hydroxylamine salts in China is expected to rebound to 87,800 tons in 2024, reflecting a growth rate of approximately 7.0% [2]. Group 2: Growth Potential - Hydroxylamine salts are focused on the green chemistry sector, aligning with environmental demands and showcasing clear growth potential [4]. - The rapid development of the new energy industry, particularly in electric vehicles and energy storage systems, is driving the demand for battery metals (lithium, cobalt, nickel), which in turn is pushing for more environmentally friendly and efficient metal extraction technologies [4][7]. Group 3: Technological Advancements - New ion exchange resin technology, characterized by low toxicity and recyclability, is becoming a core solution for green metal extraction [7]. - Hydroxylamine salts serve as a key synthetic raw material for ion exchange resins, enhancing their selectivity and stability, with recovery rates in lithium-ion battery recycling improving by over 30% compared to traditional methods [7]. Group 4: Regulatory Environment - Stricter global environmental standards are accelerating the iteration of extraction technologies, with regulations such as the EU Battery Regulation imposing strict thresholds for pollution control in metal recovery [7]. - China's "dual carbon" goals are pushing industries towards cleaner production methods, further driving the growth of the ion exchange resin market, which is expected to expand from $3.4 billion in 2022 to $5.1 billion by 2028, with a compound annual growth rate (CAGR) of 6.2% [7]. Group 5: Market Position - China is a major producer of hydroxylamine salts, with significant production scale and cost advantages, and key players include Jinhua New Materials, Aikewi, Shandong Jin'an Chemical, and others [11]. - Jinhua New Materials is leading in domestic production capacity, projected to reach 35,000 tons per year in 2024, with market share increasing from 34.86% in 2022 to 42.37% in 2024 [11]. Group 6: Market Forecast - The global hydroxylamine salt market is expected to grow from 2.714 billion yuan to 3.179 billion yuan from 2023 to 2028, with a CAGR of 3.21% [9]. - The Chinese hydroxylamine salt market is projected to increase from 1.606 billion yuan to 2.16 billion yuan from 2023 to 2029, with a CAGR of 5.06% [9].

Investment Rating - The report assigns an "Accumulate" rating for the company, indicating a positive outlook for investment [5][8]. Core Insights - The company, Jinhua New Materials, is positioned as a leading player in the fine chemical sector, focusing on oxime series products, with significant growth potential in the semiconductor market through its hydroxylamine solution [5][11]. - The company has established a robust production chain for oxime-based products, including silane crosslinking agents and hydroxylamine salts, which are expected to drive revenue growth [7][11]. - The report highlights the company's strong financial performance, with projected revenues and net profits showing significant growth from 2023 to 2027 [6][8]. Summary by Sections 1. Company Overview - Jinhua New Materials has been dedicated to the research, production, and sales of oxime series fine chemicals since its establishment in 2007, achieving a compound annual growth rate (CAGR) of 28% in revenue from 2018 to 2024 [16][22]. - The company has received multiple accolades, including recognition as a national-level specialized and innovative "little giant" enterprise [16]. 2. Business Operations - The company focuses on silane crosslinking agents and hydroxylamine salts, which are expected to see steady sales growth due to increasing market demand [22][29]. - The production capacity for silane crosslinking agents is projected to reach 58,300 tons per year by 2024, with a market share of 38.16% in China [7][11]. 3. Financial Analysis - The company anticipates revenues of approximately 1.24 billion RMB and a net profit exceeding 210 million RMB in 2024, reflecting a strong financial outlook [6][8]. - The report forecasts a net profit of 357 million RMB by 2027, with a corresponding price-to-earnings (P/E) ratio decreasing from 39 in 2025 to 22 in 2027 [6][8]. 4. Market Potential - The hydroxylamine solution is identified as a key product for entering the semiconductor chemicals market, with a projected global market growth from 206 million USD in 2023 to 378 million USD by 2030 [7][11]. - The company is also expanding its production capabilities for high-end coupling agents, which are expected to enhance its market position in functional silanes [7][11]. 5. Competitive Landscape - The company has established strong partnerships with major clients, including Bayer and Brenntag, which enhances its market competitiveness [46][47]. - The report notes that the company has overcome technical barriers in the hydroxylamine solution production, positioning it well against competitors like BASF [7][11].

Core Viewpoint - Jinhua New Materials is transitioning from a traditional chemical supplier to a high-end electronic chemical supplier through continuous technological iteration, aiming for high-quality development while maintaining both efficiency and responsibility [1]. Company Overview - Founded in 2007, Jinhua New Materials specializes in the research, production, and sales of ketoxime series fine chemicals, with key products including silane crosslinkers, hydroxylamine salts, methoxyamine hydrochloride, and acetaldehyde oxime, widely used in various sectors such as construction materials, 5G/6G, rail transportation, energy, electronics, new energy vehicles, and metal extraction [3]. - The company has established a leading market position in the silane crosslinker and hydroxylamine salt segments and has received multiple honors, including national-level manufacturing champions and green factory certifications [3]. Green Circular Industry Chain - The company has developed a proprietary "oxime-silane-hydroxylamine salt" green circular industry chain, which enhances production efficiency, cost control, and environmental friendliness [4]. - This system significantly reduces raw material consumption compared to traditional processes, minimizes waste emissions, and has established a comprehensive intellectual property system [4]. Investment Projects - Jinhua New Materials went public on the Beijing Stock Exchange in September 2025, marking a significant milestone in its development [6]. - The "60kt/a high-end coupling agent project" is a core investment project that will add 30,000 tons/year of silane coupling agent capacity and 30,000 tons/year of functional silane intermediate capacity, enhancing product variety and market competitiveness [6][8]. - The hydroxylamine aqueous solution (JH-2) pilot plant is another key investment project, crucial for extending the ketoxime industry chain and solidifying the green circular system [9]. High-End Product Development - The electronic-grade hydroxylamine aqueous solution is a critical step for the company’s transition to high-end products, primarily used as a cleaning agent in chip manufacturing [9]. - The company has successfully developed a safe and green preparation process for hydroxylamine, with plans for pilot production starting in October 2024 and expected sales of 7.60 tons in the same year [9]. Industry Positioning - Jinhua New Materials is advancing from an invisible champion to an industry benchmark by leveraging its industry chain advantages, technological accumulation, and global layout in both fine chemicals and high-end electronic chemicals [10].

Core Viewpoint - Jinhua New Materials is transitioning from a traditional chemical supplier to a high-end electronic chemical supplier through continuous technological iteration and aims for high-quality development while maintaining responsibility in its industrial upgrade [1][2]. Group 1: Company Overview - Founded in 2007, Jinhua New Materials specializes in the research, production, and sales of ketoxime series fine chemicals, with key products including silane crosslinking agents and hydroxylamine salts, widely used in various sectors such as construction, transportation, energy, electronics, and new energy vehicles [2]. - The company has established a leading market position in silane crosslinking agents and hydroxylamine salts, receiving multiple national honors such as "National Green Factory" and "National Specialized and Innovative Small Giant" [2]. Group 2: Technological Advancements - The company has developed a unique "oxime-silane-hydroxylamine salt" green circular industrial chain, which enhances production efficiency, cost control, and environmental friendliness [3]. - This industrial chain significantly reduces raw material consumption compared to traditional processes and minimizes waste emissions, contributing to the company's recognition as a "National Green Factory" [3]. Group 3: Investment and Growth Strategy - Jinhua New Materials went public on the Beijing Stock Exchange in September 2025, marking a significant milestone in its development and enhancing its brand influence and talent acquisition capabilities [4]. - The "60kt/a high-end coupling agent project" is a core investment project post-IPO, expected to add 30,000 tons/year of silane coupling agent capacity and 30,000 tons/year of functional silane intermediate capacity [4][5]. Group 4: Product Development and Market Position - The new hydroxylamine aqueous solution (JH-2) pilot plant is crucial for extending the ketoxime industrial chain and solidifying the green circular system, with electronic-grade hydroxylamine aqueous solution being a key product for the semiconductor industry [6]. - The company has successfully developed a safe and green preparation process for hydroxylamine, with plans for pilot production starting in October 2024, aiming for sales of 7.60 tons in the same year [6]. Group 5: Future Outlook - Jinhua New Materials is positioned to transition from an invisible champion to an industry benchmark, leveraging its industrial chain advantages, technological accumulation, and global layout in both fine chemicals and high-end electronic chemicals [7].

Group 1 - Zhejiang Jinhua New Materials Co., Ltd. announced the retirement of its director Wei Zhiqiang effective December 19, and proposed to nominate Zhou Lichang as the new director [1] - Jinhua New Materials, established on December 27, 2007, is set to be listed on the Beijing Stock Exchange on September 25, 2025, with the controlling party being Juhua Group Co., Ltd. and the actual controller being the Zhejiang Provincial State-owned Assets Supervision and Administration Commission [1] - The company specializes in the research, production, and sales of ketoxime series fine chemicals, with main products including silane crosslinking agents, hydroxylamine salts, and acetaldehyde oxime, positioning itself as a leading enterprise in the domestic silane crosslinking agent and hydroxylamine salt segments [1] Group 2 - Wei Zhiqiang, born in October 1965, was part of the IPO management team and has held various positions at Juhua Group, serving as a director at Jinhua New Materials since May 2021 [1] - Zhou Lichang, born on December 5, 1967, has held multiple financial roles within Juhua Group and is currently a dedicated director appointed by Juhua Group's management center [2]